- Investing Ideas
- /
- South Korean Healthcare Undervalued Stocks Based On Cash Flows
South Korean Healthcare Undervalued Stocks Based On Cash Flows
Results
3
0 new
Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.
3 companies
Boditech Med
Market Cap: ₩348.0b
Offers instruments and diagnostic reagents in South Korea and internationally.
A206640
₩15,890.00
7D
-1.5%
1Y
-9.2%
DuChemBIOLtd
Market Cap: ₩301.0b
Engages in the development, production, and sale of radiopharmaceutical products for cancer diagnosis and treatment in South Korea.
A176750
₩10,940.00
7D
3.7%
1Y
32.6%
CLASSYS
Market Cap: ₩3.8t
Provides medical aesthetics devices worldwide.
A214150
₩59,000.00
7D
1.5%
1Y
25.5%